ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,059.28
      0.33%
      US Tech 100
      20,939.60
      0.51%
      Dow Jones
      44,747.13
      0.08%
      Brent Oil
      75.935
      0.02%
      Bitcoin
      105,101.69
      1.31%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Nanobiotix SA (NBTX) Quote

      Nanobiotix SA

      Nanobiotix SA (NBTX)

      NASDAQ
      3.46
      0.09
      (2.67%)
      Closed January 29 4:00PM
      Delayed by 15 minutes
      3.46
      0.00
      ( 0.00% )
      Pre Market: 9:09AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      3.46
      Bid
      3.53
      Ask
      3.63
      Volume
      110
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      163.081M
      Previous Close
      3.46
      Open
      -
      Last Trade
      2
      @
      3.48
      Last Trade Time
      08:26:44
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      47,133,328
      Dividend Yield
      -
      PE Ratio
      -4.12
      Earnings Per Share (EPS)
      -0.84
      Revenue
      36.21M
      Net Profit
      -39.7M

      About Nanobiotix SA

      Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying ... Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its lead product candidate is NBTXR3, a preclinical research program for cancer immunotherapies. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.nanobiotix.com
      Headquarters
      Paris, Paris, Fra
      Founded
      -
      Nanobiotix SA is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NBTX. The last closing price for Nanobiotix was $3.46. Over the last year, Nanobiotix shares have traded in a share price range of $ 0.00 to $ 0.00.

      Nanobiotix currently has 47,133,328 shares outstanding. The market capitalization of Nanobiotix is $163.08 million. Nanobiotix has a price to earnings ratio (PE ratio) of -4.12.

      Ask ADVFN Intelligence (AI)

      NBTX Latest News

      More News

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      17 hours ago
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      January 21 2025
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      January 10 2025
      Edgar (US Regulatory)

      Voting Rights and Shares Capital of the Company

      In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Jan...

      January 09 2025
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 17 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 16 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 12 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 11 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 09 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 13 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      NBTX - Frequently Asked Questions (FAQ)

      What is the current Nanobiotix share price?
      The current share price of Nanobiotix is $ 3.46
      How many Nanobiotix shares are in issue?
      Nanobiotix has 47,133,328 shares in issue
      What is the market cap of Nanobiotix?
      The market capitalisation of Nanobiotix is USD 163.08M
      What is the 1 year trading range for Nanobiotix share price?
      Nanobiotix has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of Nanobiotix?
      The price to earnings ratio of Nanobiotix is -4.12
      What is the cash to sales ratio of Nanobiotix?
      The cash to sales ratio of Nanobiotix is 4.52
      What is the reporting currency for Nanobiotix?
      Nanobiotix reports financial results in EUR
      What is the latest annual turnover for Nanobiotix?
      The latest annual turnover of Nanobiotix is EUR 36.21M
      What is the latest annual profit for Nanobiotix?
      The latest annual profit of Nanobiotix is EUR -39.7M
      What is the registered address of Nanobiotix?
      The registered address for Nanobiotix is 60 RUE DE WATTIGNIES, PARIS, PARIS, 75012
      What is the Nanobiotix website address?
      The website address for Nanobiotix is www.nanobiotix.com
      Which industry sector does Nanobiotix operate in?
      Nanobiotix operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AALAmerican Airlines Group Inc
      $ 17.33
      (0.00%)
      		4.01M
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 74.435
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.89
      (0.00%)
      		4k
      AACGATA Creativity Global
      $ 0.8559
      (0.00%)
      		355
      AALAmerican Airlines Group Inc
      $ 17.33
      (0.00%)
      		4.01M
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 74.435
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.89
      (0.00%)
      		4k
      AACGATA Creativity Global
      $ 0.8559
      (0.00%)
      		355
      MGOLMGO Global Inc
      $ 0.1017
      (0.00%)
      		57.42M
      NAOVNanoVibronix Inc
      $ 0.3835
      (0.00%)
      		37.52M
      KZIAKazia Therapeutics Ltd
      $ 1.38
      (0.00%)
      		30.03M
      SPGCSacks Parente Golf Inc
      $ 0.59
      (0.00%)
      		26.76M
      BNZIBanzai International Inc
      $ 1.93
      (0.00%)
      		19.07M

      NBTX Discussion

      View Posts
      glenn1919 glenn1919 2 months ago
      NBTX.......................https://stockcharts.com/h-sc/ui?s=NBTX&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 2 months ago
      NBTX...........................https://stockcharts.com/h-sc/ui?s=NBTX&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 10 months ago
      NBTX 10Q due 4/3
      👍️0
      Monksdream Monksdream 10 months ago
      NBTX under $10
      👍️0
      Monksdream Monksdream 2 years ago
      Nanobiotix SA NASDAQ: NBTX

      GoSymbol lookup
      Health Care : Biotechnology | Small Cap Value | Based in FranceCompany profile
      Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
      This security is an American depositary receipt
      ADR Fees
      👍️0
      Monksdream Monksdream 2 years ago
      July 10, 2023
      4:21 am ET
      *Nanobiotix shares are trading higher after the company entered into a license agreement with Janssen Pharmaceutical for global co-development and commercialization of NBTXR3.
      Benzinga
      2:19 am ET
      *Nanobiotix Enters License Agreement With Janssen Pharmaceutical For Worldwide Co-Development And Commercialization Of Potential First-In-Class Radioenhancer NBTXR3
      Benzinga
      Nanobiotix SA NASDAQ: NBTX

      GoSymbol lookup
      Health Care : Biotechnology | Small Cap Value | Based in FranceCompany profile
      Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
      This security is an American depositary receipt
      ADR Fees
      👍️0

      Your Recent History

      NASDAQ
      NBTX
      Nanobiotix
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads